Literature DB >> 25374808

Why do young people with chronic kidney disease die early?

Shankar Kumar1, Richard Bogle1, Debasish Banerjee1.   

Abstract

Cardiovascular disease poses the greatest risk of premature death seen among patients with chronic kidney disease (CKD). Up to 50% of mortality risk in the dialysis population is attributable to cardiovascular disease and the largest relative excess mortality is observed in younger patients. In early CKD, occlusive thrombotic coronary disease is common, but those who survive to reach end-stage renal failure requiring dialysis are more prone to sudden death attributable mostly to sudden arrhythmic events and heart failure related to left ventricular hypertrophy, coronary vascular calcification and electrolyte disturbances. In this review, we discuss the basis of the interaction of traditional risk factors for cardiovascular disease with various pathological processes such as endothelial dysfunction, oxidative stress, low grade chronic inflammation, neurohormonal changes and vascular calcification and stiffness which account for the structural and functional cardiac changes that predispose to excess morbidity and mortality in young people with CKD.

Entities:  

Keywords:  Cardiorenal syndrome; Cardiovascular mortality; Chronic kidney disease; Endothelial dysfunction; Vascular calcification and stiffness

Year:  2014        PMID: 25374808      PMCID: PMC4220347          DOI: 10.5527/wjn.v3.i4.143

Source DB:  PubMed          Journal:  World J Nephrol        ISSN: 2220-6124


  99 in total

1.  Prevalence and predictors of nonadherence to hemodialysis.

Authors:  L G Dantas; C Cruz; M Rocha; J A Moura; E Paschoalin; S Paschoalin; C Marcilio de Souza
Journal:  Nephron Clin Pract       Date:  2013-10-16

2.  Serum homocysteine level is positively associated with chronic kidney disease in a Taiwan Chinese population.

Authors:  Min-Chun Chao; Sung-Lin Hu; Hua-Shui Hsu; Lance E Davidson; Chih-Hsueh Lin; Chia-Ing Li; Chiu-Shong Liu; Tsai-Chung Li; Cheng-Chieh Lin; Wen-Yuan Lin
Journal:  J Nephrol       Date:  2014-01-16       Impact factor: 3.902

3.  Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients.

Authors:  A Schmitz; M Vaeth
Journal:  Diabet Med       Date:  1988-03       Impact factor: 4.359

4.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

Authors:  H H Parving; H Lehnert; J Bröchner-Mortensen; R Gomis; S Andersen; P Arner
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

5.  Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.

Authors:  T Miyata; Y Wada; Z Cai; Y Iida; K Horie; Y Yasuda; K Maeda; K Kurokawa; C van Ypersele de Strihou
Journal:  Kidney Int       Date:  1997-04       Impact factor: 10.612

Review 6.  Aspects of immune dysfunction in end-stage renal disease.

Authors:  Sawako Kato; Michal Chmielewski; Hirokazu Honda; Roberto Pecoits-Filho; Seiichi Matsuo; Yukio Yuzawa; Anders Tranaeus; Peter Stenvinkel; Bengt Lindholm
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-13       Impact factor: 8.237

7.  Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.

Authors:  Mhairi K Sigrist; Maarten W Taal; Peter Bungay; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2007-10-10       Impact factor: 8.237

8.  Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease.

Authors:  Mehdi H Shishehbor; Leonardo P J Oliveira; Michael S Lauer; Dennis L Sprecher; Kathy Wolski; Leslie Cho; Byron J Hoogwerf; Stanley L Hazen
Journal:  Am J Cardiol       Date:  2008-04-09       Impact factor: 2.778

9.  Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Brian D Bradbury; Rachel B Fissell; Justin M Albert; Mary S Anthony; Cathy W Critchlow; Ronald L Pisoni; Friedrich K Port; Brenda W Gillespie
Journal:  Clin J Am Soc Nephrol       Date:  2006-11-29       Impact factor: 8.237

10.  Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study.

Authors:  Emanuele Di Angelantonio; Rajiv Chowdhury; Nadeem Sarwar; Thor Aspelund; John Danesh; Vilmundur Gudnason
Journal:  BMJ       Date:  2010-09-30
View more
  25 in total

Review 1.  Vascular calcification: When should we interfere in chronic kidney disease patients and how?

Authors:  Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim
Journal:  World J Nephrol       Date:  2016-09-06

Review 2.  Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature.

Authors:  Feby Savira; Ruth Magaye; Danny Liew; Christopher Reid; Darren J Kelly; Andrew R Kompa; S Jeson Sangaralingham; John C Burnett; David Kaye; Bing H Wang
Journal:  Br J Pharmacol       Date:  2020-05-13       Impact factor: 8.739

3.  Coronary risk score for mineral bone disease in chronic non-diabetic hemodialysis patients: results from a prospective pilot study.

Authors:  Cristiana David; Jordi Bover; Cornelia Voiculet; Ileana Peride; Lucian Cristian Petcu; Andrei Niculae; Adrian Covic; Ionel Alexandru Checherita
Journal:  Int Urol Nephrol       Date:  2016-12-18       Impact factor: 2.370

4.  Potential Role of H-Ferritin in Mitigating Valvular Mineralization.

Authors:  Katalin Éva Sikura; László Potor; Tamás Szerafin; Abolfazl Zarjou; Anupam Agarwal; Paolo Arosio; Maura Poli; Zoltán Hendrik; Gábor Méhes; Melinda Oros; Niké Posta; Lívia Beke; Ibolya Fürtös; György Balla; József Balla
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

5.  Immunohistochemistry of Kidney a-SMA, Collagen 1, and Collagen 3, in A Novel Mouse Model of Reno-cardiac Syndrome.

Authors:  Julius E Kieswich; Jianmin Chen; Samira Alliouachene; Paul W Caton; Kieran McCafferty; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  Bio Protoc       Date:  2020-09-20

6.  Calcium Disorders in the Emergency Department: Independent Risk Factors for Mortality.

Authors:  Thomas C Sauter; Gregor Lindner; Sufian S Ahmad; Alexander Benedikt Leichtle; Georg-Martin Fiedler; Aristomenis K Exadaktylos; Dominik G Haider
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

7.  The impact of intervention strategies that target arterial stiffness in end-stage renal disease: a systematic review protocol.

Authors:  Rosendo A Rodriguez; Beverley Shea; Richard Hae; Kevin D Burns
Journal:  Syst Rev       Date:  2016-07-19

8.  Whole-Mount Kidney Clearing and Visualization Reveal Renal Sympathetic Hyperinnervation in Heart Failure Mice.

Authors:  Chao Wu; Fang Yan; Min Li; Yimin Tu; Ziyu Guo; Yufei Chen; Yaxin Wu; Qing Li; Changan Yu; Yi Fu; Meihui Wu; Wei Kong; Yanxiang Gao; Xiaowei Li; Jingang Zheng
Journal:  Front Physiol       Date:  2021-07-08       Impact factor: 4.566

Review 9.  Animal Models to Study Links between Cardiovascular Disease and Renal Failure and Their Relevance to Human Pathology.

Authors:  Tim D Hewitson; Stephen G Holt; Edward R Smith
Journal:  Front Immunol       Date:  2015-09-17       Impact factor: 7.561

10.  Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells.

Authors:  Gergely Becs; Abolfazl Zarjou; Anupam Agarwal; Katalin Éva Kovács; Ádám Becs; Mónika Nyitrai; Enikő Balogh; Emese Bányai; John W Eaton; Paolo Arosio; Maura Poli; Viktória Jeney; József Balla; György Balla
Journal:  J Cell Mol Med       Date:  2015-10-26       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.